Skip Ribbon Commands Skip to main content

ARTICLES

Expression platforms

Bio-platforms of the future: New technologies will add flexibility, extend circulatory half-life
Contract Pharma, November/December 2010 

The emergence of antibody fragments and derivatives
Innovations in Pharmaceutical Technology, July 2009                          

Next Generation Pharmaceutical online editorial
Dr Dave Mead and Dr Ruth McDermott, 2008

Albumin fusions : a simple, broad platform for the production of proteins with extended circulatory half life  

Delta Biotechnology Limited, November 2005

High-level secretion of bioactive scFv antibody fragments and scFv albumin fusions by Saccaromyces  Cerevisiae

Delta Biotechnology Limited, November/December 2004

High level secretion of recombinant proteins from Saccharomyces Cerevisiae by co-expression of genes from 2µm vectors                       Delta Biotechnology Limited, November/December 2004

Microbial Fermentation                                                    BioProcess International, 2004

Yeast 2 µm plasmid copy number is elevated by a  mutation in the nuclear gene UBC4 2001                                                    

YEAST, 2001

Constitutive expression of recombinant  proteins in the methylotrophic yeast Hansenula polymorpha  using the PMAl promoter 2000                YEAST, 2000

Expression of Recombinant Platelet-Derived Endothelial Cell Growth Factor in the Yeast Saccharomyces cerevisiae   

 

Saccharomyces Cerevisiae strains that overexpress heterologous proteins
 
The secretion of human serum albumin from the yeast Saccharomyces Cerevisiae using five different leader sequences  
 

 

 

 

Copyright © 2011 Novozymes. All rights reserved.